Shifang Liu

alkermes, inc.

H指数:28

被引数:4,136

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Targeting Orexin 2 Receptors in Idiopathic Hypersomnia and Narcolepsy: A Randomised Phase 1b Proof-Of-Concept Study of Alixorexton

靶向特发性嗜睡症和发作性睡病中的食欲素2受体：一项关于Alixorexton的随机化1b期概念验证研究

Journal of Sleep Research

IF3.9

2026-08-200

OAAI

Early mortality prediction after severe trauma using ensemble machine learning: a single-center retrospective study

基于集成机器学习对严重创伤后早期死亡风险的预测：一项单中心回顾性研究

Frontiers in Public Health

IF3.4

2025-12-180

OAAI

Efficient GPU-Centered Singular Value Decomposition Using the Divide-and-Conquer Method

基于分治法的有效GPU中心奇异值分解

ACM TRANSACTIONS ON ARCHITECTURE AND CODE OPTIMIZATION

IF1.8

2025-12-010

PRE

CPR knowledge among rural grassroots healthcare workers in Xinjiang; China: a cross-sectional analysis

新疆农村基层卫生工作者心肺复苏知识：中国，一项横断面分析

Frontiers in Medicine

IF3

2025-11-210

OAAI

Cardiopulmonary resuscitation knowledge and skills among school teachers in Xinjiang; China: a cross-sectional survey

新疆地区中国学校教师的心肺复苏知识与技能：一项横断面调查

Frontiers in Public Health

IF3.4

2025-10-160

OAAI

Evaluation and comparison of machine learning algorithms for predicting discharge against medical advice in injured inpatients

评估和比较机器学习算法，以预测受伤住院患者的出院情况

SURGERY

IF2.7

2025-06-010

PRE

The Orexin 2 Receptor Agonist ALKS 2680 in Patients with Narcolepsy or Idiopathic Hypersomnia: A Phase 1b Study

Orexin 2受体激动剂ALKS 2680在发作性睡病或特发性嗜睡患者中的研究：一项1b期研究

SLEEP

IF4.9

2025-05-190

PRE

Dragon's Blood-Loaded Mesoporous Silica Nanoparticles for Rapid Hemostasis and Antibacterial Activity

MOLECULES

IF4.6

2024-04-214

OAAI

Trends and profiles of acute poisoning cases: a retrospective analysis

FRONTIERS IN PUBLIC HEALTH

IF3.4

2023-09-056

OAAI

Prevalence and genetic diversity of Theileria equi from horses in Xinjiang Uygur Autonomous region, China

TICKS AND TICK-BORNE DISEASES

IF3.4

2023-07-011

OAAI

The inhibitory effect and mechanism of Resina Draconis on the proliferation of MCF-7 breast cancer cells: a network pharmacology-based analysis

SCIENTIFIC REPORTS

IF3.9

2023-03-074

OAAI

Effectiveness of the graded transport mode for the intrahospital transport of critically ill patients: A retrospective study

FRONTIERS IN PUBLIC HEALTH

IF3.4

2023-01-133

OAAI

Effect of Dimethyl Fumarate vs Interferon β-1a in Patients With Pediatric-Onset Multiple Sclerosis The CONNECT Randomized Clinical Trial

JAMA NETWORK OPEN

IF9.7

2022-09-2823

OAAI

Isolation, Screening, and Active Metabolites Identification of Anti-Vibrio Fungal Strains Derived From the Beibu Gulf Coral

FRONTIERS IN MICROBIOLOGY

IF4.5

2022-06-025

OAAI

Transcriptomic and targeted metabolomic analysis identifies genes and metabolites involved in anthocyanin accumulation in tuberous roots of sweetpotato (Ipomoea batatas L.)

PLANT PHYSIOLOGY AND BIOCHEMISTRY

IF5.7

2020-11-0117

PREAI

Optimization of reference genes for qRT-PCR analysis of microRNA expression under abiotic stress conditions in sweetpotato

PLANT PHYSIOLOGY AND BIOCHEMISTRY

IF5.7

2020-09-0122

PREAI

Diroximel fumarate (DRF) in patients with relapsing-remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study

MULTIPLE SCLEROSIS JOURNAL

IF5

2019-11-0450

OAAI

Effect of dimethyl fumarate on lymphocytes in RRMS Implications for clinical practice

NEUROLOGY

IF8.5

2019-04-0965

OAAI

PREGNANCY OUTCOMES WITH DELAYED-RELEASE DIMETHYL FUMARATE: INTERIM RESULTS FROM AN INTERNATIONAL REGISTRY

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

IF7.5

2018-05-240

PREAI

Immune response to vaccines is maintained in patients treated with dimethyl fumarate

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION

IF7.5

2018-01-0175

OAAI

Shifang Liu

个人简介

教育背景

工作经历

荣誉奖项

研究方向